2nd Integrin-Targeted Drug Development Summit
Over the last 12 months, the integrins industry has witnessed promising data and clinical updates: 7 Hills Pharma’s new study demonstrated integrin activation can bring the heat to cold melanoma tumors and received the FDA’s Fast Track and Orphan Drug designation Caladrius Biosciences and Cend Therapeutics presented their alpha-v integrins PhIb/IIa trial data in pancreatic, colorectal and appendiceal...
